Cargando…
Improvement of depression in a patient with hypothyroidism and deiodinase polymorphism with LT3 Therapy
We report a 54‐year‐old man with treatment‐resistant depression (TRD) and hypothyroidism who responded to LT3/LT4 combination, rather than LT4 alone. He was able to discontinue all antidepressant medications eventually. Interestingly, the patient has a DIO2 polymorphism.
Autores principales: | Ahmed, Ziyan S., Sherin, Rinsha P. V., Fonseca, Tatiana L., Hoang, Thanh D., Shakir, Mohamed K. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005678/ https://www.ncbi.nlm.nih.gov/pubmed/35432999 http://dx.doi.org/10.1002/ccr3.5651 |
Ejemplares similares
-
Improvement of Treatment Resistant Depression in a Patient With Primary Hypothyroidism and Thr92Ala5’ Type 2 Deiodinase Gene Polymorphism With Multiple Daily Doses of Triiodothyronine
por: Ahmed, Ziyan, et al.
Publicado: (2021) -
Desiccated Thyroid Extract Versus Synthetic LT4/T3 Combination Versus LT4 Monotherapy in the Treatment of Primary Hypothyroidism With Special Attention to the Thr92AlaD2 Polymorphism. With Special Attention to the Gene Polymorphism
por: Hoang, Thanh Duc, et al.
Publicado: (2021) -
Low-Dose Prednisone Therapy is Efficacious in Treating Painful Subacute Thyroiditis
por: Shakir, Mohamed K M, et al.
Publicado: (2021) -
Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life
por: Tariq, Anam, et al.
Publicado: (2018) -
SUN-005 Hirsutism Due to Bilateral Leydig Cell Tumors
por: Shakir, Mohamed K M, et al.
Publicado: (2020)